Cystic Fibrosis Summit : Current Trends and Future (CFTR) Directions (Sep 23, 2017)

Cystic Fibrosis Summit : Current Trends and Future (CFTR) Directions is organized by ABCOMM, Inc. and would be held on Sep 23, 2017 at Parc 55 San Francisco, San Francisco, California, United States Of America.

The target audience for this medical event for Pediatrics. This CME Conference has been approved with a maximum of 5.50 AMA PRA Category 1 Credits.

Course Description :
Physicians and advanced practitioners involved in the management and treatment of patients with cystic fibrosis. The clinical relevance of consequential respiratory pathogens, long-term treatment study data, the role of CFTR modulators, and the impact of clinical comorbidities such as nutritional deficits and mental health issues will be discussed. Participants will collaborate on strategies to improve patient and family education, ensure smooth transitioning from pediatric to adult care, and develop techniques to help patients improve their adherence to treatment. This educational activity is designed to be highly interactive in nature and is limited to a small number of participants. This activity is supported by an educational grant from Gilead Sciences.

Conference Objectives are :
• Describe the clinical relevance and changing epidemiology of consequential respiratory pathogens.
• Select aerosolized antibiotics by comparing safety, efficacy, and long-term study data, and monitor outcomes for necessary treatment adjustments.
• Describe the evolution of CFTR modulators and decide when they are an appropriate addition to the treatment plan based on patient specific criteria including mutation analysis.
• Assess the impact of nutrition management, mental health screening, and treatment of comorbid conditions on overall patient outcomes.
• Outline current recommendations for transfer from the pediatric to the adult care setting.
• Appreciate the number and complexity of treatments and involve patients and / or family in treatment management decisions to improve adherence.
• Implement best practices to prevent the incidence and spread of infection both in the clinical setting and via patient/ caregiver education for the non-clinical setting.

Additional details will be posted as soon as they are available.